Percheron Therapeutics Stock Price, News & Analysis

ATHJY OTC

Company Description

Percheron Therapeutics (OTC: ATHJY) is a publicly traded medicinal and botanical manufacturing company in the Manufacturing sector.

ATHJY stock has gained 0.0% over the past year.

This page provides a comprehensive overview of ATHJY stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

Performance 1 year

$0.0

Market Cap

51.8M

Shares outstanding

Latest News

View All

August 22, 2022

0.00%

Long COVID-19 study identifies novel blood markers as potential diagnostic and therapeutic targets

covid-19

June 22, 2022

0.00%

New Muscle Disease Indication for ATL1102 – Limb Girdle Muscular Dystrophy R2

Percheron Therapeutics has 2 recent news articles. Key topics include covid-19. View all ATHJY news →

SEC Filings

View All

No SEC filings available for ATHJY.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

ATHJY Company Profile & Sector Positioning

Percheron Therapeutics (ATHJY) operates in the Medicinal and Botanical Manufacturing industry within the broader Manufacturing sector and is listed on the OTC.